169 related articles for article (PubMed ID: 35387127)
41. Detection of serous precursor lesions in resected fallopian tubes from patients with benign diseases and a relatively low risk for ovarian cancer.
Nishida N; Murakami F; Higaki K
Pathol Int; 2016 Jun; 66(6):337-42. PubMed ID: 27250113
[TBL] [Abstract][Full Text] [Related]
42. Immunohistochemical detection of glucose transporter GLUT1 in benign and malignant fallopian tube epithelia, with comparison to ovarian carcinomas.
Kalir T; Rahaman J; Hagopian G; Demopoulos R; Cohen C; Burstein DE
Arch Pathol Lab Med; 2005 May; 129(5):651-4. PubMed ID: 15859637
[TBL] [Abstract][Full Text] [Related]
43. [Origin of ovarian epithelial inclusions and its relationship with the development of low-grade serous carcinoma].
Xiang L; Li J; Wang LJ; Zheng WX; Kong BH
Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):729-35. PubMed ID: 22321344
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of risk-reducing salpingo-oophorectomy in BRCA1-2 variants and clinical outcomes of follow-up in patients with isolated serous tubal intraepithelial carcinoma (STIC).
Saccardi C; Zovato S; Spagnol G; Bonaldo G; Marchetti M; Alessandrini L; Tognazzo S; Guerriero A; Vitagliano A; Laganà AS; Noventa M
Gynecol Oncol; 2021 Nov; 163(2):364-370. PubMed ID: 34465478
[TBL] [Abstract][Full Text] [Related]
45. Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.
Yang J; Zhou Y; Ng SK; Huang KC; Ni X; Choi PW; Hasselblatt K; Muto MG; Welch WR; Berkowitz RS; Ng SW
BMC Cancer; 2017 Jun; 17(1):422. PubMed ID: 28623900
[TBL] [Abstract][Full Text] [Related]
46. HMGA2: a potential biomarker complement to P53 for detection of early-stage high-grade papillary serous carcinoma in fallopian tubes.
Wei JJ; Wu J; Luan C; Yeldandi A; Lee P; Keh P; Liu J
Am J Surg Pathol; 2010 Jan; 34(1):18-26. PubMed ID: 19898227
[TBL] [Abstract][Full Text] [Related]
47. High-grade serous carcinoma of unknown primary origin associated with STIC clinically presented as isolated inguinal lymphadenopathy: a case report.
Giancontieri P; Turetta C; Barchiesi G; Pernazza A; Pignataro G; D'Onghia G; Santini D; Tomao F
Front Oncol; 2023; 13():1307573. PubMed ID: 38370346
[TBL] [Abstract][Full Text] [Related]
48. Ciliated Cells in Ovarian Cancer Decrease with Increasing Tumor Grade and Disease Progression.
Richardson MT; Recouvreux MS; Karlan BY; Walts AE; Orsulic S
Cells; 2022 Dec; 11(24):. PubMed ID: 36552773
[TBL] [Abstract][Full Text] [Related]
49. Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention.
Carlson JW; Miron A; Jarboe EA; Parast MM; Hirsch MS; Lee Y; Muto MG; Kindelberger D; Crum CP
J Clin Oncol; 2008 Sep; 26(25):4160-5. PubMed ID: 18757330
[TBL] [Abstract][Full Text] [Related]
50. [Role of dysplastic changes in the uterine tubal epithelium in the histogenesis of ovarian cancer].
Danilova NV; Andreeeva IuIu; Korolev AV; Vinogradov II; Zavalishina LE; Frank GA
Arkh Patol; 2014; 76(4):9-14. PubMed ID: 25306618
[TBL] [Abstract][Full Text] [Related]
51. Signal transduction pathway activity in high-grade serous carcinoma, its precursors and Fallopian tube epithelium.
van der Ploeg P; Uittenboogaard A; Bosch SL; van Diest PJ; Wesseling-Rozendaal YJW; van de Stolpe A; Lambrechts S; Bekkers RLM; Piek JMJ
Gynecol Oncol; 2022 Apr; 165(1):114-120. PubMed ID: 35123772
[TBL] [Abstract][Full Text] [Related]
52. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
53. Protocol for the Detection of Organoid-Initiating Cell Activity in Patient-Derived Single Fallopian Tube Epithelial Cells.
Feng L; Yang W; Zhao H; Bakkum-Gamez J; Sherman ME; Kannan N
Methods Mol Biol; 2022; 2429():445-454. PubMed ID: 35507180
[TBL] [Abstract][Full Text] [Related]
54. High-grade serous ovarian and fallopian tube carcinomas with similar clinicopathological characteristics might originate from serous tubal intraepithelial carcinoma in Chinese women.
Wang J; Wu H; Zhang Y; Zhang Y; Li X; Zhao Q; Meng F; Huang Q; Wang Y
Int J Clin Exp Pathol; 2017; 10(8):8222-8232. PubMed ID: 31966673
[TBL] [Abstract][Full Text] [Related]
55. Dynamic real-time in vivo confocal laser endomicroscopy of the fallopian tube during laparoscopy in the prevention of ovarian cancer.
Chene G; Chauvy L; Buenerd A; Moret S; Nadaud B; Chabert P; Lamblin G
Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():18-23. PubMed ID: 28692889
[TBL] [Abstract][Full Text] [Related]
56. Proteomic Analysis of Pre-Invasive Serous Lesions of the Endometrium and Fallopian Tube Reveals Their Metastatic Potential.
Acland M; Arentz G; Mussared M; Whitehead F; Hoffmann P; Klingler-Hoffmann M; Oehler MK
Front Oncol; 2020; 10():523989. PubMed ID: 33384952
[TBL] [Abstract][Full Text] [Related]
57. Changes in the Extracellular Matrix Are Associated With the Development of Serous Tubal Intraepithelial Carcinoma Into High-Grade Serous Carcinoma.
van der Steen SCHA; Bulten J; Van de Vijver KK; van Kuppevelt TH; Massuger LFAG
Int J Gynecol Cancer; 2017 Jul; 27(6):1072-1081. PubMed ID: 28333845
[TBL] [Abstract][Full Text] [Related]
58. High grade serous ovarian carcinomas originate in the fallopian tube.
Labidi-Galy SI; Papp E; Hallberg D; Niknafs N; Adleff V; Noe M; Bhattacharya R; Novak M; Jones S; Phallen J; Hruban CA; Hirsch MS; Lin DI; Schwartz L; Maire CL; Tille JC; Bowden M; Ayhan A; Wood LD; Scharpf RB; Kurman R; Wang TL; Shih IM; Karchin R; Drapkin R; Velculescu VE
Nat Commun; 2017 Oct; 8(1):1093. PubMed ID: 29061967
[TBL] [Abstract][Full Text] [Related]
59. Exploring the Role of Fallopian Ciliated Cells in the Pathogenesis of High-Grade Serous Ovarian Cancer.
Coan M; Rampioni Vinciguerra GL; Cesaratto L; Gardenal E; Bianchet R; Dassi E; Vecchione A; Baldassarre G; Spizzo R; Nicoloso MS
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149579
[TBL] [Abstract][Full Text] [Related]
60. A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development.
Sherman-Baust CA; Kuhn E; Valle BL; Shih IeM; Kurman RJ; Wang TL; Amano T; Ko MS; Miyoshi I; Araki Y; Lehrmann E; Zhang Y; Becker KG; Morin PJ
J Pathol; 2014 Jul; 233(3):228-37. PubMed ID: 24652535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
